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Abstract
Ageing causes a decrease in cognitive and physical abilities, thus making the elderly
more sensitive and vulnerable. Besides, the elderly’ living conidtions are greatly affected
by various diseases and other health‐related problems. As is known, a large number of
medicines are used to treat the health‐related problems in elderly. Multiple drug use
can be named as polypharmacy,  though many definitions for “polypharmacy” are
available in the literature. Many studies are available to explain the situation of the
polypharmacy. Furthermore, there are many studies that confirm the prevalence of
polypharmacy  in  several  countries  such  as  Brazil,  the  Netherlands,  Sweden  and
Singapore. Health professionals involve in different stages of the health care services
from  the  prescription  until  the  usage  of  the  drugs.  Especially,  pharmacists  have
significant role in informing the patients about rational use of drugs. It is known that
the  metabolism  in  geriatric  patients  changes  with  ageing.  Therefore,  medications,
particularly polypharmacy, can cause serious side effect in geriatric patients. However,
effective  communication  between  the  pharmacists  and  the  patient  and  reasonable
intervention by the pharmacist could prevent the negative effects caused by medica‐
tions. In addition, an ethical perspective is crucial for considering geriatric patients’
benefit.
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1. Introduction
Due to technological developments, in the last century, the life expectancy has increased, so the
number of old people has been increasing in the world population. Baby boomers, people who
were born between 1946 and 1964, are ageing [1].
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However, the birthrate has decreased and the demographic structure of the population has
changed [2]. Furthermore, the populations in the most developed countries already have aged
[3]. For all these reasons, senility has become an important issue [4].
Senility is a special part of the life course, which differs from person to person because of several
reasons like genetic factors and lifestyle. In this period, decreased cognitive and physical
abilities make this people more sensitive and vulnerable. Besides, various diseases and other
health‐related problems affect elderly’s living conditions and life quality [5–8]. Some of the
reasons of these are as follows [9–12]:
• Some changes take place in the gastrointestinal tract.
• The liver function differentiates.
• The amount of body secretions varies.
• The amount of body water decreases.
• Because of all this, changes in absorption and effect of drugs occur.
• Reduction in sensory perception is seen frequently.
• Emotional changes can be intensely seen.
The World Health Organization defines the memory loss, urinary incontinence, depression
and falls or immobility as “four giants of geriatrics” [3, 9]. To solving all of these problems,
medication treatment comes into prominence. However, the drug response of geriatric
patience is changed because of some reasons like [13]:
• Accumulation of drugs which are eliminated by the kidneys
• Increase in drug binding
• Increase in dispersion of fat‐soluble drugs
• Decrease in dispersion of water‐soluble drugs
• Accumulation of drugs which are metabolized by liver
• Tendency to heart failure
• Variable dosage regimes
The term of “polypharmacy” originated from a Greek word “poly” which means “more than
one” generally [14, 15]. Multiple drug use can be named as polypharmacy, but there are many
different definitions for this term in the literature [14, 16–23]. Some of these definitions are
listed below:
• “Medication did not match diagnosis”
• “The use of several drugs concurrently for the treatment of one or more coexisting diseases”
• “Concurrent use of 5–9 drugs”
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• “The use of potentially inappropriate medications, which can increase the risk for adverse drug events”
Besides, according to some definitions, topical and herbal drugs, vitamin and minerals are not
included to the polypharmacy. On the other hand, the duration of therapy is important on
polypharmacy for some definitions [16].
In this context, one of the most common definitions of polypharmacy is the concurrent use of
six or more medications by a patient. The number of medications varies from 4 to 10 in different
studies [20, 21, 24–26]. In some researches, 0–4 drug use is named as non‐polypharmacy,
concurrent use of 5–9 drugs defined as polypharmacy, on the other hand 10 and more drugs
as excessive polypharmacy [21].
As is known, a large number of medicines are used to solve the health‐related problems
encountered in elderly [11, 19, 27, 28]. Also, the elderly can use many non‐prescription drugs
with prescription drugs [16, 22, 29, 30]. In order to overcome the side effects caused by drugs
used in the treatment of certain diseases, additional drugs are used, but it may cause poly‐
pharmacy [16].
There are several problems that may be caused of polypharmacy. In general, the reduction of
water consumption and the increase in the body’s water supply with ageing, and even in some
cases starting to use taking medicaments with food instead of water, is one of these problems.
Besides, some other problems that may arise can be listed as below [16, 18, 31, 32]:
• Drug‐drug interactions,
• Drug‐food interactions,
• Adverse drug reactions,
• Compliance problems,
• Increasing emotional problems,
• Various financial problems.
For all this reason, polypharmacy is a particular concern for all community, especially elderly.
2. Polypharmacy practices in the world
It is known that major medication safety concern in elderly patients is polypharmacy and
potentially inappropriate medication use [24]. Polypharmacy draws the attention as an
increasingly critical problem in the health care systems, especially on the geriatric patients
around the world.
Many studies are available to explain the situation of the polypharmacy in the literature. Most
of the studies are made in nursing homes where elderly people live in close quarters [20, 21,
28, 33].
According to the results of a longitudinal study made by Veehof et al., polypharmacy is
increasing [33]. Furthermore, there are many studies, which confirm the prevalence of
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polypharmacy from several counties like Brazil, the Netherlands, Sweden and Singapore [16,
18, 20, 24, 28, 31, 34, 35].
There are also some researches about the commonly used drugs for geriatric patients. Some of
the most widely used drugs in geriatrics are as follows [13, 24, 34, 35]:
• Proton pump inhibitors
• H2 receptor blockers
• Beta‐blockers
• Diuretics
• Statins
• ACE inhibitors
• Non‐steroidal anti‐inflammatory drugs
Drug‐drug interaction is an important problem for polypharmacy in geriatric patients. Some
studies are focused to this problem [36, 37].
Some drugs combination like carbamazepine‐nifedipine, warfarin‐acetic acid derivate,
haloperidol‐escitalopram, Ginkgo biloba‐warfarin are defined as “drugs that should not be
combined” because of their dangerous interactions [37]. These interactions can be resulted with
possible increased bleeding risk or drug concentration problems [37].
In addition to these, the drug interaction risk must be considered during the use of some drugs
like cimetidine, sucralfate, ketoconazole, omeprazole, phenobarbital and clomipramine [36].
One of the important studies about polypharmacy in geriatric patient is SHELTER Study from
the Europe. This study includes 4156 nursing home residents from seven European Union
countries. According to the results of this research, 49.7% of the residents use 5–9 drugs and
24.3% of the residents use 10 or more drugs [21, 38].
In another study, Junius‐Walker et al. found that most of the prescription and non‐prescription
drug consumers are elderly in Germany [32]. The study sample contained 466 geriatric patients
and 26.7% of them were on prescribed polypharmacy. When the OTC user was included to
them, this ratio increased to 53.6% [32].
Cankara et al. have investigated the polypharmacy presence in a university hospital in Turkey
[35]. According to this study, most of the polypharmacy patients were middle aged and elderly.
A hospitalized geriatric patient used 340 different active substances during 30 days [35].
In Spain, San‐Jose et al. showed that polypharmacy became prevalent in patients and older
than the younger elderly [34]. Besides, they stated that potentially inappropriate medicine is
associated with polypharmacy during the use of 10 or more drugs [34].
An important result of polypharmacy is drug‐related problems. Finkers et al. found that 96%
of the geriatric polypharmacy patients in the Netherlands’ nursing homes had one or more
drug‐related problem like decreased renal function and elevated liver enzymes [20]. Poly‐
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pharmacy is a common practice to treat geriatric patients; also, it was found in 58.59% of the
nursing home residents [28].
Like many other countries in the world, polypharmacy is also widespread among geriatric
patients in Sweden. Moreover, Haider et al. revealed that there are significant differences in
drug use in different educational groups of geriatric patients [24].
3. The role of pharmacists and other health care professionals in
polypharmacy
Health professionals involve in different stages of the health care services from the prescription
until the usage of the drugs [14, 19]. Geriatric patients are an important part of the patient
group on briefing because of their cognitive abilities. Especially, pharmacists as the most easily
accessible health professionals have significant role on informing of the patients about rational
drug use [4, 27].
Pharmacists show ultimate attention to provide information to the patients [39]. Particularly
with the spread of self‐treatment efforts, the role of the pharmacists has become more impor‐
tant [40].
Especially geriatric patients use non‐prescribed drugs as well as the prescribed drugs [29], and
this situation may cause major problems. Old patients, due to their chronic diseases, since they
use more drugs than other age groups and they are more likely to be under risk, they are
frequently in communication with their pharmacists [41].
In addition to these, there are many reasons of geriatric patients’ pharmacy visits [4]:
• Buying prescription and non‐prescription drugs,
• Consulting about their health status,
• Getting vaccine injections,
• Learning to use some medical devices,
• Measuring blood pressure,
• Chatting.
In pharmacy selections of the elderly patients, the quality of the services provided by the
pharmacy and the pharmacist’s characteristics play an important role. It is indicated that
geriatric patients prefer responsible, friendly and cooperative pharmacists [41].
In addition, geriatric patients are expecting the pharmacists to give them information like side
effects of the medications and drug‐drug interactions [19, 27, 31, 41]. During these briefings,
asking open‐ended questions makes it easier to understand probable problems [8]. Moreover,
counselling services that can be provided along with are thus aligned as follows [4]:
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• To control the drug interaction
• To listen to the patient with patience
• To counsel according to patient status
• To continue the counselling process until the patient understands
It should be noted the importance that it will provide important benefits to In order for
pharmacists to make appropriate interventions about the use of drugs, it is necessary that the
pharmacy service is patient oriented and the relationship between the patient and the phar‐
macist is important [4, 31, 39, 41].
Furthermore, the pharmacist‐physician communication is also important to improve patient
care [27, 42]. With an appropriate communication between them can prevent possible medi‐
cation errors. Also, with this collaboration, geriatric patients’ drug compliance gets easier.
Pharmacists have to be more careful when taking the geriatric patient’s medication history and
medication use‐misuse choices should be considered. Especially, it is important to be careful
about non‐prescribed drugs [29].
Among health service providers, pharmacists take an important place and to provide better
service, they have to have sufficient information to make appropriate interventions [42].
During their undergraduate educations, the pharmacists must have detailed information
about the geriatric patients, and if it is provided, the service they provide will be more qualified
[43].
The physicians’ poor prescribing practices are also a common reason of the negative effects of
polypharmacy [44]. Therefore, physicians’ care and attentions have a core importance.
In addition, in the health services provided to the elder people, at common approaches that
lead to various problems particularly like polypharmacy, to prevent patient injury, all health
personnel should be working as a team.
In necessary cases, while prescribing appropriate drugs, physicians should cooperate with the
pharmacists and the nurses while tracking and applying the drugs for the patients who are
hospitalized and who are staying in nursing homes should come together with the pharmacists
in necessary cases, and this will minimize the problems faced by the use of drug of older
patients.
Moreover, at various problems that the patients in question are facing, orienting the patients
to the specialists like physiotherapists and dieticians who are experts in their fields will
contribute positively to the quality of life of the patients.
4. Salient points on polypharmacy
It is known that many changes take place on geriatric patient’s metabolism. Therefore, side
effects of medications have negative impact on geriatric patients, particularly polypharmacy.
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Pharmacokinetic changes are one of the most common reasons of polypharmacy’s harmful
effects on geriatric patients. Some of these changes are listed below [45–48]:
• Absorption problems can be occurring because of the high gastric pH, insufficient absorp‐
tion space and gastrointestinal motility. Because of these, solubility and chemical stability
of drugs can be changed and active transport can be decreased. In addition to these, the risk
of esophageal lesions can be increased.
• The composition of body and the permeability of blood‐brain barrier can be changed.
Moreover, protein‐binding sites can be reduced. These changes affect the distribution of
drugs, for example, changes on the volume of distribution for lipo‐soluble drugs and water‐
soluble drugs.
• Decrease on the activity of cytochrome P450 and hepatic blood flow affect the metabolism.
• Excretion also changes because of the decreased rate of glomerular filtration and tubular
secretion. These cause problems on the elimination of water‐soluble drugs.
However, an effective communication between the pharmacists and the patient and reasonable
intervention by the pharmacist could prevent these negative effects [19, 25, 27].
Some of the important points that the other health personnel with the pharmacists should pay
attention in the application of polypharmacy for the geriatric patients are listed as below:
• While informing the patients with vision loss occurring by senility, caution should be
exercised. In cases where written information should be given, attention should be paid to
the preparation of the articles can be read easily.
• Especially in some regions, it should not be forgotten that some geriatric patients’ reading
level is low. In those types of cases, especially while preparing reminders regarding when
and how to use the drugs, it would be useful to use pictograms.
• Hearing loss is common in geriatric patients is a condition that should not be forgotten
during providing health services. Especially while informing those patients, it is necessary
to set the voice tone appropriately.
• It would be helpful to use special drug cases for easy tracking especially for the patients
who have memorial problems like dementia. If necessary, the related health personnel
should come into play while placing the pills to the boxes that will be used daily, weekly
and monthly.
• It should be considered that the geriatric patients’ physical strength may be decreased and
especially the drug packages, which are developed to protect the children, should be packed
by using different packages for the elderly.
Also, an ethical perspective is crucial for considering geriatric patients’ benefit. Like in the
other patient groups, for the provision of the pharmacy services by especially paying attention
to the secrecy of the geriatric patients, there must be a separate place in pharmacies to protect
privacy [40].
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Besides, in some cases, dementia has caused some problems with regard to informed consent
and autonomy, which are important ethical component. Therefore, attention should be paid
to taking geriatric patients’ history and informing them. Health care professionals must be
more careful especially during the polypharmacy.
Also, the principle of justice should not be forgotten during the allocation of limited health
resources [49]. It is known that there is no clear solution for these kinds of ethical dilemmas
[50]. However, the vulnerability of the geriatric patients should be always considered and
health care professionals should give particular importance their beneficence and autonomy
[51]. With all that, the principle of non‐maleficence must be considered using the evidence‐
based treatments for geriatric patients [52].
In conclusion, to decrease negativity that may be originated from polypharmacy, the cooper‐
ation of the health personnel and the patient relatives is of great importance. Together with
adopting and generalizing rationalist drug use, reaching the requested treatment results,
increasing the life quality of patients and decreasing the costs would be possible.
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